SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-257692
Filing Date
2022-10-04
Accepted
2022-10-04 17:29:26
Documents
15
Period of Report
2022-10-04
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d238484d8k.htm   iXBRL 8-K 30156
2 EX-23.1 d238484dex231.htm EX-23.1 1664
3 EX-99.1 d238484dex991.htm EX-99.1 1070096
  Complete submission text file 0001193125-22-257692.txt   1426088

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA dna-20221004.xsd EX-101.SCH 4134
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dna-20221004_def.xml EX-101.DEF 14076
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE dna-20221004_lab.xml EX-101.LAB 23494
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dna-20221004_pre.xml EX-101.PRE 15102
9 EXTRACTED XBRL INSTANCE DOCUMENT d238484d8k_htm.xml XML 5578
Mailing Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210
Business Address 27 DRYDOCK AVENUE 8TH FLOOR BOSTON MA 02210 (877) 442-5362
Ginkgo Bioworks Holdings, Inc. (Filer) CIK: 0001830214 (see all company filings)

IRS No.: 872652913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40097 | Film No.: 221293254
SIC: 2836 Biological Products, (No Diagnostic Substances)